Anthony P. Heaney

9.7k total citations · 1 hit paper
122 papers, 5.7k citations indexed

About

Anthony P. Heaney is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology. According to data from OpenAlex, Anthony P. Heaney has authored 122 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Endocrinology, Diabetes and Metabolism, 31 papers in Surgery and 30 papers in Epidemiology. Recurrent topics in Anthony P. Heaney's work include Pituitary Gland Disorders and Treatments (83 papers), Growth Hormone and Insulin-like Growth Factors (22 papers) and Neuroendocrine Tumor Research Advances (21 papers). Anthony P. Heaney is often cited by papers focused on Pituitary Gland Disorders and Treatments (83 papers), Growth Hormone and Insulin-like Growth Factors (22 papers) and Neuroendocrine Tumor Research Advances (21 papers). Anthony P. Heaney collaborates with scholars based in United States, United Kingdom and Netherlands. Anthony P. Heaney's co-authors include Шломо Мелмед, Manory Fernando, Gregory A. Horwitz, William H. Yong, Donal J. Buggy, Masahiro Nakashima, Marvin Bergsneider, Run Yu, Zhiyong Wang and Viera Nelson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Anthony P. Heaney

116 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas

2017 390 citations Gérald Raverot, Pia Burman et al. European Journal of Endocrinology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anthony P. Heaney United States	39	3.4k	1.6k	1.6k	1.2k	1.1k	122	5.7k
Wolfgang Saeger Germany	41	4.4k 1.3×	1.3k 0.8×	1.4k 0.9×	2.6k 2.1×	1.5k 1.4×	304	6.6k
Shozo Yamada Japan	41	3.7k 1.1×	921 0.6×	1.5k 0.9×	1.8k 1.5×	1.2k 1.1×	229	5.0k
Gilbert J. Cote United States	46	2.9k 0.8×	3.3k 2.1×	1.0k 0.6×	1.4k 1.2×	254 0.2×	141	7.3k
Lawrence S. Kirschner United States	36	1.5k 0.4×	1.6k 1.0×	466 0.3×	2.0k 1.6×	319 0.3×	100	5.4k
Lionel Groussin France	38	2.4k 0.7×	1.2k 0.7×	329 0.2×	2.8k 2.3×	445 0.4×	134	5.1k
Cristina Romei Italy	42	4.9k 1.4×	1.8k 1.1×	1.1k 0.7×	1.4k 1.1×	194 0.2×	122	6.5k
Klaus Kaserer Austria	40	1.8k 0.5×	722 0.5×	1.4k 0.9×	1.3k 1.1×	158 0.1×	108	4.4k
Brigitte Delemer France	32	2.0k 0.6×	536 0.3×	973 0.6×	1.3k 1.1×	248 0.2×	143	3.8k
Fabio Rotondo Canada	29	1.1k 0.3×	893 0.6×	515 0.3×	610 0.5×	754 0.7×	108	2.6k
Matthias Kroiß Germany	37	2.1k 0.6×	987 0.6×	191 0.1×	2.9k 2.4×	980 0.9×	174	4.7k

Countries citing papers authored by Anthony P. Heaney

Since Specialization

Citations

This map shows the geographic impact of Anthony P. Heaney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony P. Heaney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony P. Heaney more than expected).

Fields of papers citing papers by Anthony P. Heaney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony P. Heaney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony P. Heaney. The network helps show where Anthony P. Heaney may publish in the future.

Co-authorship network of co-authors of Anthony P. Heaney

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony P. Heaney. A scholar is included among the top collaborators of Anthony P. Heaney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony P. Heaney. Anthony P. Heaney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Raverot, Gérald, Pia Burman, Ana Paula Abreu, et al.. (2025). Revised European Society of Endocrinology Clinical Practice Guideline for the management of aggressive pituitary tumours and pituitary carcinomas. European Journal of Endocrinology. 192(6). G1–G34. 3 indexed citations

2.

Favero, Vittoria, Davide Paolo Bernasconi, Alessandro Maloberti, et al.. (2025). Cardiometabolic Risk Parameters in “Nonfunctioning” Adrenal Incidentalomas: A Systematic Review and Meta-analysis. The Journal of Clinical Endocrinology & Metabolism. 111(2). e619–e629. 1 indexed citations

3.

Newell‐Price, John, Maria Fleseriu, Rosario Pivonello, et al.. (2024). Improved Clinical Outcomes During Long-term Osilodrostat Treatment of Cushing Disease With Normalization of Late-night Salivary Cortisol and Urinary Free Cortisol. Journal of the Endocrine Society. 9(1). bvae201–bvae201. 6 indexed citations

4.

Zhang, Dongyun, et al.. (2024). Whole-exome sequencing reveals genetic variants that may play a role in neurocytomas. Journal of Neuro-Oncology. 166(3). 471–483.

5.

Biller, Beverly M. K., Maria Fleseriu, Rosario Pivonello, et al.. (2023). THU041 Clinical Improvements In Patients With Cushing’s Disease Treated With Osilodrostat According To Urinary And Late-night Salivary Cortisol Levels: Pooled Analysis From LINC 3 And LINC 4. Journal of the Endocrine Society. 7(Supplement_1). 1 indexed citations

6.

Gadelha, Mônica R., Marie Bex, Richard A. Feelders, et al.. (2022). Randomized Trial of Osilodrostat for the Treatment of Cushing Disease. The Journal of Clinical Endocrinology & Metabolism. 107(7). e2882–e2895. 66 indexed citations

7.

Ben-Shlomo, Anat, John D. Carmichael, Christina Wang, et al.. (2022). Treatment of Cushing Disease With Pituitary-Targeting Seliciclib. The Journal of Clinical Endocrinology & Metabolism. 108(3). 726–735. 16 indexed citations

8.

Fleseriu, Maria, Richard J. Auchus, Yona Greenman, et al.. (2022). Levoketoconazole treatment in endogenous Cushing's syndrome: extended evaluation of clinical, biochemical, and radiologic outcomes. European Journal of Endocrinology. 187(6). 859–871. 20 indexed citations

9.

Raverot, Gérald, Pia Burman, Ann McCormack, et al.. (2017). European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas. European Journal of Endocrinology. 178(1). G1–G24. 390 indexed citations breakdown →

10.

Strosberg, Jonathan, Þorvarður R. Hálfdánarson, Andrew M. Bellizzi, et al.. (2017). The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine Tumors. Pancreas. 46(6). 707–714. 262 indexed citations

11.

Yuen, Kevin C.J., Anthony P. Heaney, & Vera Popović. (2016). Considering GH replacement for GH-deficient adults with a previous history of cancer: a conundrum for the clinician. Endocrine. 52(2). 194–205. 11 indexed citations

12.

Öberg, Kjell, Irvin M. Modlin, Wouter W. de Herder, et al.. (2015). Consensus on biomarkers for neuroendocrine tumour disease. The Lancet Oncology. 16(9). e435–e446. 206 indexed citations

13.

McLaughlin, Nancy, Neil A. Martin, Ausaf Bari, et al.. (2014). Assessing the cost of contemporary pituitary care. Neurosurgical FOCUS. 37(5). E7–E7. 15 indexed citations

14.

Heaney, Anthony P.. (2014). Management of aggressive pituitary adenomas and pituitary carcinomas. Journal of Neuro-Oncology. 117(3). 459–468. 58 indexed citations

15.

Heaney, Anthony P.. (2004). Novel medical approaches for the treatment of Cushing’s disease. Journal of Endocrinological Investigation. 27(6). 591–595. 5 indexed citations

16.

Heaney, Anthony P., Manory Fernando, & Шломо Мелмед. (2003). PPAR-γ receptor ligands: novel therapy for pituitary adenomas. Journal of Clinical Investigation. 111(9). 1381–1388. 144 indexed citations

17.

Heaney, Anthony P., Manory Fernando, & Шломо Мелмед. (2002). Functional role of estrogen in pituitary tumor pathogenesis. Journal of Clinical Investigation. 109(2). 277–283. 122 indexed citations

18.

Heaney, Anthony P., Manory Fernando, & Шломо Мелмед. (2002). Functional role of estrogen in pituitary tumor pathogenesis. Journal of Clinical Investigation. 109(2). 277–283. 156 indexed citations

19.

Zhang, Xun, Gregory A. Horwitz, Anthony P. Heaney, et al.. (1999). Pituitary Tumor Transforming Gene (PTTG) Expression in Pituitary Adenomas. The Journal of Clinical Endocrinology & Metabolism. 84(2). 761–767. 323 indexed citations

20.

Heaney, Anthony P.. (1999). Is whole-lung CT scanning still necessary in all cases of ACTH-dependent Cushing's syndrome in the era of petrosal sinus sampling?. QJM. 92(6). 335–340. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact